PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Regeneron Pharmaceuticals Inc, Tarrytown, New York.\', \'Department of Medicine, University of Pennsylvania, Philadelphia.\', \'Department of Microbiology, University of Pennsylvania, Philadelphia.\', \'Department of Global Health, University of Washington, Seattle.\', \'Division of Allergy and Infectious Diseases, University of Washington, Seattle.\', \'Department of Epidemiology, University of Washington, Seattle.\', \'Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.\', \'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.\', \'Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill.\', \'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.\', \'Department of Biostatistics, University of Washington, Seattle.\', \'Clinical Trials of Florida LLC, Miami.\', \'Medical Research of Westchester, Miami, Florida.\', \'Catalina Research Institute LLC, Montclair, California.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jama.2021.24939
?:hasPublicationType
?:journal
  • JAMA
is ?:pmid of
?:pmid
?:pmid
  • 35029629
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35029629>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35029629>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all